| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/26/2008 | US20080153867 Alzheimer's disease, cognitive disorders, memory disorders, dementia, attention deficit disorder, traumatic brain injury, drug dependence, addiction; -chloro-N-{[3-(4-chlorophenyl)-4-phenyl-4,5-dihydro-1H-pyrazolyl]-[7-(1,2,3,4-tetrahydroacridin-9-ylamino)heptylamino]methylene}benzene-sulfonamide |
| 06/26/2008 | US20080153866 Amorphous Taclolimus Solid Dispersion Having an Enhanced Solubility and Pharmaceutical Composition Comprising Same |
| 06/26/2008 | US20080153865 Water soluble paclitaxel derivatives |
| 06/26/2008 | US20080153864 Spiroazabicyclic Heterocyclic Compounds |
| 06/26/2008 | US20080153863 Spiropiperidine derivatives |
| 06/26/2008 | US20080153862 Vasopressin receptor (V1a) antagonists, treatment of anxiety and depressive disorders and other diseases |
| 06/26/2008 | US20080153861 Vasopressin receptor (V1a) antagonists, treatment of anxiety and depressive disorders and other diseases |
| 06/26/2008 | US20080153860 3H-(4's)-1'-azaspiro[benzofuran-2,4']-tricyclo[3.3.1.13,7]decane; for therapy of memory disorder, cognitive disorder, neurodegeneration, and neurodevelopmental disorder; attention deficit disorder, attention deficit hyperactivity disorder (ADHD), Alzheimer's disease (AD), mild cognitive impairment |
| 06/26/2008 | US20080153859 5-{[6-Fluoro-2,5-dihydroxy-4,4,7-dimethyl-2-(trifluoromethyl)-1,2,3,4-tetrahydronaphthalen-1-yl]amino}-isoquinolin-1(2H)-one; anti-allergic, immunosuppressive and antiproliferative action |
| 06/26/2008 | US20080153858 Antitumorigenic drug combination |
| 06/26/2008 | US20080153857 Specific capsaicin receptor modulators; analgesics; neuropathic pain; obesity; antitussives, hiccups; e.g. (4-Cyclopropyl-phenyl)-[2-methoxymethyl-7-(3-trifluoromethyl-pyridin-2-yl)-quinazolin-4-yl]-amine |
| 06/26/2008 | US20080153856 3-Ethyl-1-propyl-8-{1-[(3-trifluoromethylphenyl)methyl]pyrazol-4-yl}-1,3,7-trihydropurine-2,6-dione; antiasthmatic and antidiarrhea agents |
| 06/26/2008 | US20080153855 Chemical Compounds |
| 06/26/2008 | US20080153854 Novel fused heterocycles and uses thereof |
| 06/26/2008 | US20080153853 Use of mtki 1 for treating or preventing brain cancer |
| 06/26/2008 | US20080153852 Tryptophan hydroxylase inhibitors; anticarcinogenic agents; gastrointestinal, cardiovascular, and respiratory system disorders |
| 06/26/2008 | US20080153851 Cycloalkyl Piperidine Tachykinin Receptor Antagonists |
| 06/26/2008 | US20080153850 Adamantyl Derivates as P2x7 Receptor Antagonists |
| 06/26/2008 | US20080153849 Aqueous solution of calcium folinate and hydrochloric acid or acetic acid are added to stirred water; filtration, centrifuging; washing solid with cold water and solvent; drying under low pressure; concentrated, stable injection or infusion solutions; rescue agent for high doses of methotrexate |
| 06/26/2008 | US20080153848 Crystalline Base of Trans-1-((1R,3S)-6-Chloro-3-Phenylindan-1-Yl)-3,3-Dimethylpiperazine |
| 06/26/2008 | US20080153847 Process for Making Trans-1-((1R,3S)-6-Chloro-3-Phenylindan-1-Yl)-3,3-Dimethylpiperazine |
| 06/26/2008 | US20080153846 Especially 1-(5-((R)-2-Amino-1-phenylpropan-2-yl)-1,3,4-oxadiazol-2-yl)methyl)-4-butylpiperazine-2,3-dione or derivatives; amyloid precursor protein-cleaving enzyme |
| 06/26/2008 | US20080153845 Administering N-(4-tert-butylphenyl)-4-(3-chloropyridin-2-yl)tetrahydropryazine-1(2H)-carboxamide (BCTC) to inhibit unpleasant bitter, sour, hot/peppery, irritating, pungent, and astringent tastes; foods, drugs |
| 06/26/2008 | US20080153844 3-(Benzimidazol-2-yl)pyrazole derivatives; inhibitors of ATP and protein kinase interactions; diabetes, rheumatoid arthritis, Crohn's disease, septic shock, cachexia, pancreatitis, Alzheimer's disease, Parkinson's disease; antimetastasis, anticarcinogenic, antitumor, antidepressant, antiallergen agents |
| 06/26/2008 | US20080153843 Bradykinin 1 receptor (B1R) antagonists for treating various inflammatory diseases, pain, obesity; compounds bind to both rat and human receptors for pharmacological testing; ether and amide-functional N-heterocycle sulfonamides |
| 06/26/2008 | US20080153842 Synergistic mixture of a thiazolecarboxamide derivative, especially N-(2-Chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamide, and an antiproliferative cytotoxic agent such as paclitaxel, procarbazine, mitoxantrone or an epidophyllotoxin |
| 06/26/2008 | US20080153841 Treatment of premature ejaculation |
| 06/26/2008 | US20080153840 Reduction of cardiovascular symptoms |
| 06/26/2008 | US20080153839 Stimulating epidermal renewal, improving radiance of the complexion and/or the grain of the skin and/or for smoothing out the skin's microrelief, and/or for attenuating age spots; topically applying anisic acid or alkyl ester; skin disorders, moisturizers; wrinkle and aging resistance |
| 06/26/2008 | US20080153838 Compounds Having Tie2 (Tek) Activity |
| 06/26/2008 | US20080153837 4-(Benzimidazol-2-yl)fluorene and 4-(azabenzimidazol-2-yl)fluorene derivatives; treating disorders related to Hsp90 protein; anticarcinogenic, antimetastasis, antitumor, anticoagulant, antiproliferative, antihistamine, and antidiabetic agents; metabolic, muscular, rheumatic and nervous system disorders |
| 06/26/2008 | US20080153836 1H-Quinazoline-2,4-Diones |
| 06/26/2008 | US20080153835 Therapeutic agents useful for treating pain |
| 06/26/2008 | US20080153834 Certain Substituted Amides, Method of Making, and Method of Use Thereof |
| 06/26/2008 | US20080153833 Substituted pteridines for the treatment of inflammatory diseases |
| 06/26/2008 | US20080153832 Synergistic mixture with antispasmodic agent, a barbiturate, a tranquilizer, a selective serotonin reuptake inhibitor, or a 5-HT3 receptor antagonist; gastrointestinal disorders, Crohn's disease, irritable bowel syndrome, diarrhea, vomiting, dyskinesias, incontinence, pain, inflammatory bowel disease |
| 06/26/2008 | US20080153831 prevention and treatment of osteoporosis are provided herein. The compositions contain one or more isoflavones, such as genistein and derivatives thereof, in combination with one or more folates, such as a reduced folate and/or folic acid; and/or one or more polyunsaturated fatty acids (PUFAs), |
| 06/26/2008 | US20080153830 methods for treating pain, including pain associated with chronic inflammatory diseases, neuropathic pain and cancer by using alpha -adrenergic antagonists and beta -adrenergic agonists (particularly beta 2-adrenergic agonists) alone or in combination. |
| 06/26/2008 | US20080153829 Pan-alpha-2 receptor agonist and 5ht4 serotonin receptor compositions for treating gastrointestinal motility disorders |
| 06/26/2008 | US20080153828 Imidazopyridazine Compounds |
| 06/26/2008 | US20080153827 treatment or prevention of cardiac hypertrophy or diastolic heart failure resulting from cardiac hypertrophy by administering levosimendan or its metabolite (II) or any of their pharmaceutically acceptable salts to a mammal in need of such treatment |
| 06/26/2008 | US20080153826 substituted aryl cycloalkanoyl derivatives, compositions containing these derivatives, and methods of their use for the prevention and treatment of conditions ameliorated by monoamine reuptake including, inter alia, vasomotor symptoms (VMS), sexual dysfunction, gastrointestinal and genitourinary disorder |
| 06/26/2008 | US20080153825 Alpha-2b receptor agonist and 5ht4 serotonin receptor compositions for treating gastrointestinal motility disorders |
| 06/26/2008 | US20080153823 a group of aryl ureas in treating raf mediated diseases, and pharmaceutical compositions for use in such therapy |
| 06/26/2008 | US20080153822 Methods of treating pain |
| 06/26/2008 | US20080153821 Nitrogen-containing 5-membered ring compound |
| 06/26/2008 | US20080153820 pharmaceutically acceptable salt thereof or prodrug thereof, and the use thereof in therapy and in the treatment or prevention of a disorder in which the blocking of purine receptors, particularly adenosine receptors and more particularly A2A receptors, may be beneficial, |
| 06/26/2008 | US20080153819 Methods for treating macular edema and pathologic ocular angiogenesis using a neuroprotective agent and a receptor tyrosine kinase inhibitor |
| 06/26/2008 | US20080153818 Methods for preventing inflammation during surgery |
| 06/26/2008 | US20080153817 Treatment for Alzheimer's Disease and Related Conditions |
| 06/26/2008 | US20080153816 Indole Compounds, Method of Preparing Them and Uses Thereof |
| 06/26/2008 | US20080153815 Pinane-substituted pyrimidinediamine derivatives useful as axl inhibitors |
| 06/26/2008 | US20080153814 8-Chloro-2,3-Benzodiazepine Derivatives |
| 06/26/2008 | US20080153813 for using 6-aminoimidazo[1,2-b]pyridazine analogs are disclosed herein to treat rho kinase-mediated diseases or rho kinase-mediated conditions, including controlling intraocular pressure and treating glaucoma, are disclosed. Ophthalmic pharmaceutical compositions useful in the treatment of eye diseases |
| 06/26/2008 | US20080153812 Novel compounds |
| 06/26/2008 | US20080153811 methods for treating, managing and preventing cognitive impairment associated with various diseases and disorders, age-associated memory impairment, and dementia. |
| 06/26/2008 | US20080153810 novel indazole that may be used as melanin concentrating hormone receptor ligands, methods of preparing such compounds, compositions containing such compounds, and methods of using such compounds to treat MCH related disorders. |
| 06/26/2008 | US20080153809 Novel amides useful for treating pain |
| 06/26/2008 | US20080153808 pharmaceutical composition comprising a serotonin-norepinephrine reuptake inhibitor and a pan-alpha-2 receptor agonist. The composition is effective for treating chronic pain, and methods of treating pain using the composition and compounds comprising it |
| 06/26/2008 | US20080153807 fused 1,2,4-triazoles for modulating the activity of 11 beta -hydroxysteroid dehydrogenase type 1 (11 beta HSD1) and the use of these compounds as pharmaceutical compositions has been described. Also a novel class of fused 1,2,4-triazoles, their use in therapy, pharmaceutical compositions |
| 06/26/2008 | US20080153806 diagnostic test and method is provided comprising mixing blood or another biological fluid sample with a test compound and spotting the blood on filter paper for subsequent analysis of the effect of the test compound on the blood. The biological fluid can be a cerebrospinal |
| 06/26/2008 | US20080153805 Sulfonamide derivatives |
| 06/26/2008 | US20080153804 Gamma D-Crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it |
| 06/26/2008 | US20080153803 Gamma-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it |
| 06/26/2008 | US20080153802 Benzoyl urea derivatives mimicing BH3-only proteins, able to interact with a Bcl-2 protein |
| 06/26/2008 | US20080153801 Benzoxazepine compounds, their production and use |
| 06/26/2008 | US20080153800 3-{[5-(azetidin-1-ylcarbonyl)pyrazin-2-yl]oxy}-5-[(1-methylethyl)oxy]-N-1H-pyrazol-3-ylbenzamide; glucokinase (GLK or GK) activator; type II diabetes |
| 06/26/2008 | US20080153799 Novel Quinoline-Carbaxamides as Jak3 Kinase Modulators |
| 06/26/2008 | US20080153798 Methods of inhibiting nitric oxide synthase using corrin derivatives |
| 06/26/2008 | US20080153797 Identifying compounds that can treat autoimmune conditions; ulcerative colitis, inflammatory bowel disease, Crohn's disease, psoriasis, actinic keratosis, arthritis, multiple sclerosis, optic neuritis |
| 06/26/2008 | US20080153796 Promotion of wound contraction |
| 06/26/2008 | US20080153795 Medicaments and methods for wound healing |
| 06/26/2008 | US20080153794 Medicaments and methods for wound healing |
| 06/26/2008 | US20080153793 Coatings comprising self-assembled molecular structures and a method of delivering a drug using the same |
| 06/26/2008 | US20080153792 Drug Identification and Treatment Method |
| 06/26/2008 | US20080153791 Administering (2S,4aS,6aS,6bR,8aR,10S,12aS,12bR,;14bR)-10-(2-Carboxy-phenoxy)-2,4a,6a,;6b,9,9,12a-heptamethyl-13-oxo-1,2,;3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,;12a,12b,13,14b-icosahydro-picene-2-;carboxylic acid methyl ester; metabolic diseases, cancer, cell proliferation, glaucoma, |
| 06/26/2008 | US20080153790 Polymer coatings as carriers for the drug delivery of a derivative of a methoxyaminocarbonyloxy-rapamycin and another drug(s) such as an antiproliferative agent, anticoagulant, etc.; reduces restenosis in vasculature procedures; to a level of 0-25%; coronary/periferal stents; grafts ; balloons |
| 06/26/2008 | US20080153789 Testosterone analog or gonadotrophin releasing hormone analog in a topical carrier; micro or nanoparticles; disorders of the subcutaneous fatty tissue |
| 06/26/2008 | US20080153788 Two ketosteroids of 3,17-diketoandrost-1,4,6-triene, 6-methylene-3-keto-17-hydroxylandrost-1,4-diene, 6-bromo-alpha-3,17-diketoandrost-1,4-diene and 6-bromo-beta-3,17-diketoandrost-1,4-diene and a carrier |
| 06/26/2008 | US20080153787 Progestational and antimineralocorticoid activity |
| 06/26/2008 | US20080153786 Controlled release of drugs into/through the skin |
| 06/26/2008 | US20080153785 Pharmaceutical Compositions Containing Biophosphonate for Improving Oral Absorption |
| 06/26/2008 | US20080153784 Salt of a bisphosphonate anda salt of pentavalent phosphorus oxoacid; osteoporosis |
| 06/26/2008 | US20080153783 Pyrimidyl Phosphonate Antiviral Compounds and Methods of Use |
| 06/26/2008 | US20080153782 Phosphatidylcholine, phosphatidylinositol, phosphatidylethanolamine, phosphatidylserine and shingomyeline esterified by docosahexaensic acid or eicosapentaenoic acid |
| 06/26/2008 | US20080153781 Applying 4-(2,4-bistrimethylsilyphenylcarboxamide) benzoic acid; warts, eczema, dandruff |
| 06/26/2008 | US20080153780 Applying resiniferatoxin in the intracapsular space or in the bursa of joints; wound pain after surgery, arthrosis, rheumatoid arthritis, infectious arthritis, chondrocalcinosis |
| 06/26/2008 | US20080153779 Comprising an active agent, a delivery agent compound, and at least one of a swellable polymer (polyethylene oxide), a release controlling polymer (polyacrylic acid), or a mucoadhesive |
| 06/26/2008 | US20080153778 5-(Methoxymethyl)-1-(5-methyl-4-(thiophen-2-yl)pyrimidin-2-yl)-N-(pyridin-4-ylmethyl)-1H-pyrazole-4-carboxamide; for the treatment or prevention of type 2 diabetes and type 2 diabetes-related conditions |
| 06/26/2008 | US20080153776 Administering to an eye an aqueous solution of alginate having a minimum of about 50% mannuronate residues based upon the total number of saccharide monomeric units; no active pharmaceutical agent |
| 06/26/2008 | US20080153775 Weight reduction program and method |
| 06/26/2008 | US20080153774 4' -C-substituted-2-haloadenosine derivative |
| 06/26/2008 | US20080153773 Inhibits modulation of Protein phosphatase 2A (PP2A) by PTPA; and ATPase inhibitors; used to treat disorders in which PTPA ATPase activity |
| 06/26/2008 | US20080153772 Oligonucleotides For Rna Interference and Biological Applications Thereof |
| 06/26/2008 | US20080153771 Selective inhibition of pro-angiogenic biochemical pathways, including inhibition of the VEGF pathway gene expression and inhibition localized at pathological neovascularization (NV) tissues; cancer, ocular disease, arthritis, and inflammatory diseases |
| 06/26/2008 | US20080153770 Expression Vectors with Improved Safety |
| 06/26/2008 | US20080153769 A nucleic acid ligand whose sequence optionally includes a 2'-O-methyl modification and/or a 2'-O-fluoro modification, useful for inhibiting coagulation in a host undergoing a therapeutic regime such as surgery or coronary artery bypass |
| 06/26/2008 | US20080153768 Treatment of neurological disorders by dsrna administration |
| 06/26/2008 | US20080153767 Modulation of forkhead box o1a expression |
| 06/26/2008 | US20080153766 Non-insulin dependent diabetes mellitus; lowers hepatic fatty degeneration; improving liver function by reducing alanine transaminase and aspartate transaminase levels |